Prof. Ahituv shared his labs work with us on April 1st. Prof. Ahituv is an advisor to two companies working to cure diseases like SYNGA1: Encoded Therapeutics & Regel Therapeutics. His lab is also part of a team from across UCSF, UC Berkeley & the University of Washington that recently secured a grant from the Weill Neurohub. This grant was to look a haploinsufficencies and SYNGAP1 is one of the explicit targets.

You may also like

SynGAP modulates the body's biological clock: What Syngap1 mice can tell us about light & sleep

Sydney Aten, PhD

Ohio State University

Types of seizures and EEG patterns in SYNGAP1

Angel Aledo-Serrano, MD, PhD

Hospital Ruber Internacional (Madrid) & Clinica Corachan (Barcelona)

Functional assessment of missense variants of SYNGAP1

Kurt Haas, PhD

University of British Columbia